SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d)
Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): December 14, 2017 (December 12, 2017)
MRI INTERVENTIONS, INC.
(Exact name of registrant as specified in
(State or other jurisdiction
Irvine, Ca. 92618
(Address of principal executive offices,
(Registrant’s telephone number, including
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Company ☒
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
As a result of a reduction
in board size and increased responsibilities of the members of the Board of Directors (the “Board”) of MRI Interventions,
Inc. (the “Company”) following the Company’s 2017 annual meeting of stockholders, in order to continue
to attract and retain qualified members of the Board and to compensate them appropriately for their services, the Compensation
Committee of the Board engaged an independent compensation consultant to perform a benchmarking analysis, evaluating the Board’s
compensation relative to its peer companies and market compensation practices.
Based on the results of
the compensation consultant’s analysis, the Compensation Committee of the Board recommended on December 12, 2017, to the
Board, and the Board approved an appropriate revision of the MRI Interventions, Inc. Non-Employee Director Compensation Plan (the
“Director Plan”), which had not been revised since 2013.
The foregoing description
of the amended Director Plan is only a summary and is qualified in its entirety by the full text of the amended Director Plan,
the form of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.
||Financial Statements and Exhibits.|
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: December 14, 2017
|MRI INTERVENTIONS, INC.|
||/s/ Harold A. Hurwitz|
||Harold A. Hurwitz|
||Chief Financial Officer|